Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹1,646 Cr
up ₹121 Cr vs Jul 2023
- Stocks held
- 25
- up 1 vs Jul 2023
- Top 10 weight
- 67.5%
- of the portfolio in its ten largest
- Cash & debt
- 3.2%
- cash, money market and debt
- Moves this month
- 1 in · 0 out
- added to 8, trimmed 15
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In August 2023 it disclosed 25 stocks worth ₹1,646 Cr, up ₹121 Cr from Jul 2023. Its largest positions were Sun Pharmaceutical Industries Limited (13.8%), Cipla Limited (10.0%), Lupin Limited (7.3%); the ten largest together made up 67.5% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 74.6% of its equity. Cash and debt stood at 3.2%. Compared with Jul 2023 the fund entered 1 new stock and exited 0.
Against 229 other Sectoral / Thematic funds
Concentration
93%
Top-10 weight is higher than 93% of peers
Breadth
8%
Holds more stocks than 8% of peers
Cash
46%
Holds more cash than 46% of peers
What these mean: concentration · cash
Holdings in August 2023
Download CSVEvery line the fund disclosed, with the change against Jul 2023. Click a column to sort; click a company to see every fund that owns it. New to these? How to read a portfolio.
| Sun Pharmaceutical Industries Limited | 13.76% | down 1.52 pts | ₹226 Cr | down ₹6.5 Cr | Trimmed |
| Cipla Limited | 10.03% | down 0.09 pts | ₹165 Cr | up ₹10.8 Cr | Added |
| Lupin Limited | 7.29% | up 0.70 pts | ₹120 Cr | up ₹19.5 Cr | Added |
| Suven Pharmaceuticals Limited | 6.55% | up 0.68 pts | ₹108 Cr | up ₹18.2 Cr | Added |
| IPCA Laboratories Limited | 6.05% | up 1.28 pts | ₹99.6 Cr | up ₹26.8 Cr | Added |
| Alembic Pharmaceuticals Limited | 5.82% | down 0.44 pts | ₹95.8 Cr | up ₹28 L | Held |
| Apollo Hospitals Enterprise Limited | 5.45% | down 0.87 pts | ₹89.6 Cr | down ₹6.7 Cr | Trimmed |
| Procter & Gamble Health Limited | 4.70% | down 0.90 pts | ₹77.4 Cr | down ₹8 Cr | Trimmed |
| Alkem Laboratories Limited | 4.15% | down 0.74 pts | ₹68.4 Cr | down ₹6.3 Cr | Trimmed |
| Concord Biotech Limited | 3.70% | up 3.70 pts | ₹60.8 Cr | up ₹60.8 Cr | New |
| Vijaya Diagnostic Centre Limited | 3.23% | up 0.22 pts | ₹53.1 Cr | up ₹7.3 Cr | Added |
| Cash, TREPS & receivables | 3.16% | up 0.31 pts | ₹52.1 Cr | up ₹8.6 Cr | Added |
| Intuitive Surgical Inc | 2.95% | down 0.34 pts | ₹48.5 Cr | down ₹1.6 Cr | Trimmed |
| Zydus Lifesciences Limited | 2.91% | down 0.26 pts | ₹47.9 Cr | down ₹49 L | Trimmed |
| Aarti Drugs Limited | 2.57% | down 0.33 pts | ₹42.2 Cr | down ₹1.9 Cr | Trimmed |
| Indoco Remedies Limited | 2.44% | down 0.19 pts | ₹40.1 Cr | up ₹1 L | Held |
| Mankind Pharma Limited | 2.13% | down 0.09 pts | ₹35.1 Cr | up ₹1.2 Cr | Added |
| ICICI Lombard General Insurance Company Limited | 1.93% | down 0.27 pts | ₹31.7 Cr | down ₹1.7 Cr | Trimmed |
| Kovai Medical Center and Hospital Limited | 1.87% | down 0.17 pts | ₹30.8 Cr | down ₹28 L | Trimmed |
| Globus Medical Inc | 1.82% | down 0.36 pts | ₹30 Cr | down ₹3.2 Cr | Trimmed |
| Abbott Laboratories | 1.63% | down 0.26 pts | ₹26.9 Cr | down ₹2.1 Cr | Trimmed |
| Taro Pharmaceutical Industries Limited | 1.38% | up 0.13 pts | ₹22.8 Cr | up ₹3.7 Cr | Added |
| Unichem Laboratories Limited | 1.35% | up 0.49 pts | ₹22.2 Cr | up ₹9 Cr | Added |
| Global X Funds - Global X Genomics & Biotechnology ETF Fund units | 1.12% | down 0.19 pts | ₹18.5 Cr | down ₹1.6 Cr | Trimmed |
| MedPlus Health Services Limited | 0.95% | down 0.26 pts | ₹15.6 Cr | down ₹2.8 Cr | Trimmed |
| Illumina Inc | 0.70% | down 0.17 pts | ₹11.5 Cr | down ₹1.8 Cr | Trimmed |
| Pfizer Limited | 0.35% | down 0.05 pts | ₹5.8 Cr | down ₹27 L | Trimmed |
What changed, Jul 2023 to Aug 2023
New New positions (1)
- Concord Biotech Limited3.7% · ₹60.8 Cr
Exited Exited (0)
None.
Added Biggest additions
- IPCA Laboratories Limitedup ₹26.8 Cr (+1.28% pts)
- Lupin Limitedup ₹19.5 Cr (+0.70% pts)
- Suven Pharmaceuticals Limitedup ₹18.2 Cr (+0.68% pts)
- Cipla Limitedup ₹10.8 Cr (−0.09% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Jul 2023, the weight rose most in Pharmaceuticals & Biotechnology (+2.2 pts), and fell most in Healthcare Services (−1.0 pts) and Healthcare Equipment & Supplies (−0.7 pts).
- Pharmaceuticals & Biotechnology72.4% → 74.6%+2.2 pts
- Healthcare Services12.8% → 11.7%−1.0 pts
- Healthcare Equipment & Supplies5.7% → 5.0%−0.7 pts
- Insurance2.3% → 2.0%−0.3 pts
- Retailing1.3% → 1.0%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Aug 2020 | Aug 2022 | Feb 2023 | May 2023 | Jul 2023 | Aug 2023 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 64.7% | 56.9% | 68.0% | 71.2% | 72.4% | 74.6% |
| Healthcare Services | 19.9% | 26.0% | 16.8% | 13.3% | 12.8% | 11.7% |
| Pharmaceuticals | 9.0% | 7.6% | 6.0% | 5.8% | 5.6% | 5.7% |
| Healthcare Equipment & Supplies | 3.6% | 5.5% | 5.8% | 6.2% | 5.7% | 5.0% |
| Insurance | 2.7% | 2.7% | 2.3% | 2.3% | 2.3% | 2.0% |
| Retailing | — | 1.2% | 1.1% | 1.3% | 1.3% | 1.0% |
Allocation in Aug 2023change vs Jul 2023
- Pharmaceuticals & Biotechnology (14)74.6%▲ 2.2 pts
- Healthcare Services (4)11.7%▼ 1.0 pts
- Pharmaceuticals (3)5.7%
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal. More on reading cash.
Cash & debt, Aug 2023
3.2%
▲ 0.3 pts vs Jul 2023
- Cash alone
- 3.2%
- cash and net receivables
- A year earlier
- 0.3%
- Aug 2022 · now ▲ 2.8 pts
- Last 12 months
- <0.1% – 4.2%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.